skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon Pharma Report StoreRecommendationsProduct loginProductLogin
Global Search Configuration

Executive Summary

The 21st Century Cures bill made it through the US Congress in 2016 after all; advocates can thank the unexpected presidential victory of Donald Trump for helping to make that happen.

 

Like many prominent Republicans, House Energy & Commerce Committee Chairman Fred Upton was not excited when the party selected Donald Trump as its presidential candidate. In fact, he very publicly declined to endorse Trump ahead of the GOP convention and just as publicly called on him to drop out of the race in October after the Access Hollywood video was released.

But, now that Upton’s 21st Century Cures bill is on its way to President Obama for signature, the Michigan Republican should probably send Trump a thank-you note.


Upton launched the Cures effort in 2014 and shepherded it through the House in 2015, eager to complete work before his tenure as E&C Committee chair ends with the adjournment of the current Congress.


Heading into election day, the chances that Upton would be able to celebrate the accomplishment were looking bleak. The Senate had repeatedly missed deadlines to bring a companion bill to the floor for a vote, with the final hope a promise to take up the bill in the post-election “lame duck” session.

 

 

Find out more about Medtech Insight here

 



Read also

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.
Contact Customer Services

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now